| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | 8HF8FIN815 |
| Parent Compound: | AMIFAMPRIDINE |
Structure
| InChI Key | KAICRBBQCRKMPO-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C5H10N3O4P |
| Molecular Weight | 207.13 |
| AlogP | 0.25 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 64.93 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 8.0 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lambert-Eaton Myasthenic Syndrome | 4 | D015624 | FDA |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Brugada Syndrome | 3 | D053840 | ClinicalTrials |
| Muscular Atrophy, Spinal | 2 | D009134 | ClinicalTrials |
| Muscular Atrophy | 2 | D009133 | ClinicalTrials |
Related Entries
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3301611 |
| EPA CompTox | DTXSID40196254 |
| FDA SRS | 8HF8FIN815 |
| PubChem | 9920716 |
| SureChEMBL | SCHEMBL3958357 |
CONTENTS